Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
fertility treatment
|
| gptkbp:companyStatus |
OvaScience ceased operations in 2018
|
| gptkbp:controversy |
regulatory scrutiny
effectiveness questioned |
| gptkbp:developedBy |
gptkb:OvaScience
|
| https://www.w3.org/2000/01/rdf-schema#label |
AUGMENT fertility treatment
|
| gptkbp:introducedIn |
2014
|
| gptkbp:involves |
egg cell rejuvenation
mitochondrial transfer |
| gptkbp:status |
not FDA approved
offered in select countries |
| gptkbp:usedFor |
in vitro fertilization
assisted reproductive technology |
| gptkbp:bfsParent |
gptkb:OvaScience
|
| gptkbp:bfsLayer |
6
|